Hydroanthracene based compounds as anticancer agents
CA 2523019 A1 · Owner: Sairam, Kalapatapu V. V. M. · Inventors: Mukherjee, Rama; Sesha, Giri Venkatachalam; Dutta, Sankar Kumar
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of novel anthracene based compounds for the inhibition or prevention of the growth or multiplication of cancer cells and , to therapeutic compositions containing such compounds.The invention relates more specifically to the use of hydroanthracene based compounds for the inhibition and/or prevention of cancer of the colon pancreas, prostate, lung, larynx, ovary breast, glioblastoma, oral cavity, endothelial cells and leukemias. The agents of the invention form a distinct class distinct from , the anthracene, anthrone or anthraquinone derivatives.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 30, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 30, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 30, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.